Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era.

Publication Type:

Journal Article


Urology (2015)


To evaluate population-based survival trends, compared to optimistic trial benchmarks, in metastatic renal cell carcinoma (mRCC). Advances in medical therapy for mRCC may be associated with survival improvements. Yet, targeted therapy trial results focus on patients with favorable-risk mRCC and may not be well disseminated at the population level.